Please find a list of the latest GBS publications below:

‘Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections’, by Adrian M Piliponsky, Kavita Sharma, Phoenicia Quach, Alyssa Brokaw, Shayla Nguyen, Austyn Orvis, Siddhartha S Saha, Nyssa Becker Samanas, Ravin Seepersaud, Yu Ping Tang, Emily Mackey, Gauri Bhise, Claire Gendrin, Anna Furuta, Albert J Seo, Eric Guga, Irina Miralda, Michelle Coleman, Erin L Sweeney, Charlotte A Bäuml, Diana Imhof, Jessica M Snyder, Adam J Moeser, Lakshmi Rajagopal, The Journal of Clinical Investigation, Oct 2022


‘Virulence, Phenotype and Genotype Characteristics of Invasive Group B Streptococcus Isolates Obtained from Swedish Pregnant Women and Neonates.’ Huebner EM, Gudjonsdottir MKJ, Dacanay MB, Nguyen S, Brokaw A, Sharma K, Elfvin A, Hentz E, Rivera YR, Burd N, Coler B, Li M, Li A, Munson J, Jacobsson B, Rajagopal L, Adams Waldorf KM, Annals of Clinical Microbiology and Antimicrobials, October 2022


‘Molecular Epidemiology of Group B Streptococci in Lithuania Identifies Multi-Drug Resistant Clones and Sporadic ST1 Serotypes Ia and Ib’, by Jonah Rodgus, Ruta Prakapaite, Panagiotis Mitsidis, Ramune Grigaleviciute, Rita Planciuniene, Povilas Kavaliauskas, Elita Jauneikaite, Pathogens, September 2022.


Group B Strep in Pregnancy & Babies Conference, 12-13 July 2022: Abstracts, Sage Journals, September 2022, https://journals.sagepub.com/doi/full/10.1177/20499361221112979


‘How GBS Got Its Hump: Genomic Analysis of Group B Streptococcus from Camels Identifies Host Restriction as well as Mobile Genetic Elements Shared across Hosts and Pathogens’, Chiara Crestani, Dinah Seligsohn, Taya L. Forde and Ruth N. Zadoks, Pathogens, September 2022


‘Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy, Alyssa Brokaw, Anna Furuta, Matthew Dacanay, Lakshmi Rajagopal, Kristina M Adams Waldorf, Frontiers in Cellular and Infection Microbiology, September 2021


‘A Novel Conserved Protein in Streptococcus agalactiae, BvaP, Is Important for Vaginal Colonization and Biofilm Formation’, by Lamar S. Thomas, Laura C. Cook, mSphere, Volume 7, Issue 4, August 2022


‘Race and Ethnicity in Neonatal Group B Streptococcal Disease in England: 2016–2020’, Simon M. Collin, Alicia Demirjian, Catherine Swann, Theresa Lamagni, Pediatrics, e2021056080, August 2022


‘Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS colonisation of vaginal epithelial cells’, by Mohamed Deifallah Yousif, Arif Felek, Manolya Saydam, Seanette Wilson, Sudaxshina Murdan, Fatme Mawas. Vaccine, Volume 40, Issue 42, July 2022


‘The landscape of antimicrobial resistance in the neonatal and multi-host pathogen group B Streptococcus: review from a One Health perspective’, by Oliveira LMA, Simões LC, Costa NS, Zadoks RN, Pinto TCA. Frontiers in Microbiology, July 2022


‘The Streptococcus agalactiae R3 surface protein is encoded by sar5’, Adelle Basson, Camilla Olaisen, Linn-Karina Selvik, Randi Valsø Lyng, Hilde Lysvand, Alexandre Gidon, Christina Gabrielsen Aas, Jan Egil Afset, Marte Singsås Dragset, PLOS ONE, July 2022


‘Group B Streptococcus (GBS) colonization is dynamic over time, whilst GBS capsular polysaccharides-specific antibody remains stable’, by I L Haeusler, O Daniel, C Isitt, R Watts, L Cantrell, S Feng, M Cochet, M Salloum, S Ikram, E Hayter, S Lim, T Hall, S Athaide, C A Cosgrove, J S Tregoning, K Le Doare., Clinical and Experimental Immunology, July 2022


‘Short-term and long-term risk of mortality and neurodevelopmental impairments after bacterial meningitis during infancy in children in Denmark and the Netherlands: a nationwide matched cohort study’, Linde Snoek, Bronner P Gonçalves, Erzsébet Horváth-Puhó, Merel N van Kassel, Simon R Procter, Kirstine K Søgaard, Jaya Chandna, Arie van der Ende, Prof Diederik van de Beek, Matthijs C Brouwer, Henrik T Sørensen, Prof Joy Lawn, Merijn W Bijlsma, The Lancet. Child & Adolescent Health, July 2022


‘Population genomics of Group B Streptococcus reveals the genetics of neonatal disease onset and meningeal invasion’, Chrispin Chaguza, Dorota Jamrozy, Merijn W. Bijlsma, Taco W. Kuijpers, Diederik van de Beek, Arie van der Ende & Stephen D. Bentley, Nature Communications, No.13, July 2022


Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. By Bronner Gonçalves, Epidemiologist at London School of Hygiene and Tropical Medicine, The Lancet Global Health, June 2022


‘Characteristics of Streptococcus agalactiae Colonizing Nonpregnant Adults Support the Opportunistic Nature of Invasive Infections’, Elisabete R Martins, Dulce Nascimento do Ó, Ana Luísa Marques Costa, José Melo-Cristino, Mário Ramirez, ASM Microbiology Spectrum, e0108222, May 2022


‘CodY Is a Global Transcriptional Regulator Required for Virulence in Group B Streptococcus.’ Angelica Pellegrini, Germana Lentini, Agata Famà, Andrea Bonacorsi, Viola Camilla Scoffone, Silvia Buroni, Gabriele Trespidi, Umberto Postiglione, Davide Sassera, Federico Manai, Giampiero Pietrocola, Arnaud Firon, Carmelo Biondo, Giuseppe Teti, Concetta Beninati and Giulia Barbieri, Frontiers in Microbiology, 13, 881549, April 2022


Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina’. By Proma Paul, Research Fellow, London School of Hygiene and Tropical Medicine, Lancet eClinical Medicine, April 2022


‘A recombinant alpha-like protein subunit vaccine (GBS-NN) provides protection in murine models of Group B Streptococcus infection’, Alyssa Brokaw, Shayla Nguyen, Phoenicia Quach, Austyn Orvis, Anna Furuta, Bengt Johansson-Lindbom, Per B Fischer, Lakshmi Rajagopal, The Journal of Infectious Diseases, jiac148, April 2022


‘Control of Streptococcal Infections: Is a Common Vaccine Target Achievable Against Streptococcus agalactiae and Streptococcus pneumoniae, Edmund Bedeley, Andrea Gori, Dorothy Yeboah-Manu, Kanny Diallo, Frontiers in Microbiology, April 2022


‘Identifying large-scale recombination and capsular switching events in Streptococcus agalactiae strains causing disease in adults in the UK between 2014 and 2015’, Uzma Basit Khan, Elita Jauneikaite​, Robert Andrews, Victoria J. Chalker, Owen B. Spiller, Microbial Genomics, Volume 8, Issue 3, March 2022


‘Epidemiology of Invasive Infections Caused by Streptococcus agalactiae in Argentina’, Bárbara Arias, Verónica Kovacec, Laura Vigliarolo, Mariana Suárez, Carina Tersigni, Horacio Lopardo, Marta Mollerach, Laura Bonofiglio, Observational Study, Microbial Drug Resistance, Volume 28, Issue 3, March 2022


‘Bacterial and Host Determinants of Group B Streptococcal Infection of the Neonate and Infant’, Anna Furuta, Alyssa Brokaw, Gygeria Manuel, Matthew Dacanay, Lauren Marcell, Ravin Seepersaud, Lakshmi Rajagopal, Kristina Adams Waldorf, Frontiers in Microbiology, Feb 2022